Adamis Pharmaceuticals | ADMP - Gross Profit On Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Adamis Pharmaceuticals

Adamis Pharmaceuticals reported $-335070 in Gross Profit on Sales for its fiscal quarter ending in March of 2023.


Gross Profit On Sales Change
Adamis Pharmaceuticals ADMP:US USD -335070 3.96K
Cara Therapeutics CARA:US USD 3.58M 2.44M
GlaxoSmithKline GSK:LN GBP 5.05B 151M
Glaxosmithkline GSK:US GBP 5.05B 151M
Merck & Co MRK:US USD 11.14B 1.15B
Pfizer PFE:US USD 13.26B 1.21B
RedHill Biopharma RDHL:US USD 4.2M 3.9M